Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Equity Ratio (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Equity Ratio for 13 consecutive years, with 0.53 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 224.42% year-over-year to 0.53, compared with a TTM value of 0.53 through Dec 2025, up 224.42%, and an annual FY2025 reading of 0.53, up 224.42% over the prior year.
  • Equity Ratio was 0.53 for Q4 2025 at Abvc Biopharma, down from 0.57 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.67 in Q2 2022 and bottomed at 0.06 in Q2 2021.
  • Average Equity Ratio over 5 years is 0.38, with a median of 0.43 recorded in 2022.
  • The sharpest move saw Equity Ratio surged 1054.71% in 2022, then plummeted 78.06% in 2023.
  • Year by year, Equity Ratio stood at 0.65 in 2021, then plummeted by 47.83% to 0.34 in 2022, then tumbled by 44.69% to 0.19 in 2023, then dropped by 12.97% to 0.16 in 2024, then surged by 224.42% to 0.53 in 2025.
  • Business Quant data shows Equity Ratio for ABVC at 0.53 in Q4 2025, 0.57 in Q3 2025, and 0.58 in Q2 2025.